Search Results
Mar 06, 2026, 08:42 ET The Growing Link Between Glutathione and Cognitive Health (And How Continual-G Can Help)
of the relevance of glutathione (GSH) levels as they pertain to neurodegenerative diseases, including Multiple Sclerosis (MS), Parkinson's Disease (PD), and Alzheimer's Disease (AD). The overall message was "GSH depletion contributes to impaired immune and antioxidant activity in neurodegenerative diseases."Current
More news about: Continual-G
Mar 06, 2026, 07:43 ET A série nubia Neo 5 será lançada no MWC Barcelona 2026 contando com o único ventilador integrado em sua categoria.
dure o dia todo, o nubia Neo 5 GT vem equipado com uma bateria de duas células de 6210 mAh, combinada com carregamento ultrarrápido de até 80 W (45 W PD para o mercado da UE). Para jogadores assíduos, o carregamento sem fio (Bypass Charging) alimenta o telefone diretamente, sem carregar a bateria, durante
More news about: ZTE Corporation
Mar 06, 2026, 04:08 ET Se lanza nubia Neo 5 Series en MWC Barcelona 2026 con el único ventilador incorporado de su clase
que dure todo el día, el nubia Neo 5 GT incorpora una potente batería de doble celda de 6210 mAh, combinada con carga superrápida de hasta 80 W (45 W PD para el mercado de la UE). Para los jugadores más exigentes, la carga por derivación alimenta el teléfono directamente sin cargar la batería mientras
More news about: ZTE Corporation
Mar 05, 2026, 21:48 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elevance Health, Inc. - ELV
its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug ('MA-PD') plans and suspending certain communication activities to Medicare beneficiaries." Elevance said that "CMS has indicated that the proposed sanctions
More news about: Pomerantz LLP
Mar 05, 2026, 17:31 ET Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight
decide on next steps in collaboration with their healthcare provider.In February 2026, Agilent Technologies obtained FDA clearance for its PD-L1 IHC 22C3 pharmDx assay to be used as a companion diagnostic for individuals with epithelial ovarian, fallopian tube, or primary peritoneal cancer.In
More news about: DelveInsight Business Research, LLP
Mar 05, 2026, 15:38 ET De nubia Neo 5-serie wordt op MWC Barcelona 2026 gelanceerd, met de enige ingebouwde ventilator in zijn klasse
dat u de hele dag lang kunt winnen, heeft de nubia Neo 5 GT een zeer grote 6210 mAh dual-cell batterij, gekoppeld aan tot 80W Super Fast Charging (45W PD voor de EU-markt). Voor verstokte gamers: Bypass Charging voorziet de telefoon direct van stroom zonder dat u de batterij tijdens het gamen moet opladen.Onderdompelende
More news about: ZTE Corporation
Mar 05, 2026, 15:30 ET La série nubia Neo 5 sera présentée au MWC de Barcelone 2026 avec le seul ventilateur intégré de sa catégorie
succès dure toute la journée, le nubia Neo 5 GT embarque une énorme batterie à deux cellules de 6210 mAh, associée à une charge super rapide de 80 W (45 W PD pour le marché de l'UE). Pour les joueurs invétérés, la fonction Bypass Charging permet d'alimenter directement le téléphone sans charger la batterie
More news about: ZTE Corporation
Mar 05, 2026, 07:56 ET GNTbm's self-developed anti-cancer new drug GNTbm-38 has obtained IND approval from the U.S. FDA for Phase I clinical trials
potential. It can be used in combination with drugs of different mechanisms, including unique multi-kinase inhibitors, immune checkpoint inhibitors, or anti-PD-1/VEGF bispecific antibodies, generating stronger synergistic anti-cancer effects and providing patients with better treatment benefits.About
More news about: Great Novel Therapeutics Biotech & Medicals Corporation
Mar 05, 2026, 07:35 ET 華上生醫自主開發抗癌新藥GNTbm-38獲得美國FDA臨床一期試驗的IND核准
經規劃GNTbm-38的臨床多個適應症開發策略，將優先開發復發或難治的外周T細胞淋巴癌，取得孤兒藥授予資格；再擴增新適應症。GNTbm-38是屬於一個廣普性、口服、抗癌新藥，開發潛力巨大，可以與多種不同機制藥物聯合使用，可聯合的用藥包括獨特的多重激酶抑制劑、免疫檢查點抑制劑、或anti-PD-1/VEGF雙特異性抗體等藥物，產生更強大的協同性抗癌療效，提供病患更好的治療效益。關於GNTbm-38GNTbm-38 是由華上生醫所自主開發的最新一代癌症免疫療法的樞紐藥物，已經獲得美國FDA的IND核准進入臨床一期試驗。它是藉由一個具免疫健全的腫瘤負荷動物測試平台所篩選出的抗癌候選藥物，並經多項臨床前研究，確認其在腫瘤免疫方面具有非常出色的抗癌活性。GNTbm-38
More news about: 華上生醫
Mar 05, 2026, 01:24 ET Fapon Biopharma präsentiert CD3/TCR VHH TCE-Plattform der nächsten Generation auf dem 19. Annual European Life Sciences CEO Forum
Die Plattform hat bereits erfolgreich die Evaluierung abgeschlossen und dabei eine überlegene Wirksamkeit und Sicherheit sowie eine vorhersagbare PK/PD in Studien mit Mäusen und NHP gezeigt.Fapon Biopharma verfügt über ein hervorragendes CMC-Profil und Flexibilität bei der Formatierung von mehrwertigen
More news about: Fapon Biopharma
Mar 04, 2026, 21:26 ET Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
(nominal p = 0.035).Cadonilimab Provides Sustained Long-Term Survival Benefit Irrespective of PD-L1 Expression StatusThe COMPASSION-03 study enrolled more than 18% of patients with PD-L1 CPS < 1, and 36% of participants had received ≥2 prior lines of systemic therapy. Study findings
More news about: Akeso, Inc.
Mar 04, 2026, 10:12 ET nubia Neo 5 Series Launches at MWC Barcelona 2026 with the Only Built-in Fan in its Class
To ensure the winning streak lasts all day, nubia Neo 5 GT packs a massive 6210mAh dual-cell battery, paired with up to 80W Super Fast Charging (45W PD for EU market). For heavy gamers, Bypass Charging directly powers the phone without charging the battery while gaming.Immersive Gaming Experience
More news about: ZTE Corporation
Mar 04, 2026, 09:42 ET nubia Neo 5 Series Launches at MWC Barcelona 2026 with the Only Built-in Fan in its Class
To ensure the winning streak lasts all day, nubia Neo 5 GT packs a massive 6210mAh dual-cell battery, paired with up to 80W Super Fast Charging (45W PD for EU market). For heavy gamers, Bypass Charging directly powers the phone without charging the battery while gaming.Immersive Gaming Experience
More news about: ZTE Corporation
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
primary endpoints. With a novel dual-targeting mechanism against PD-1 and CTLA-4, cadonilimab demonstrates superior efficacy and a favorable safety profile compared to combination therapies. It has shown strong anti-tumor activity regardless of PD-L1 status and holds breakthrough potential in IO-resistant
More news about: Akeso, Inc.
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
primary endpoints. With a novel dual-targeting mechanism against PD-1 and CTLA-4, cadonilimab demonstrates superior efficacy and a favorable safety profile compared to combination therapies. It has shown strong anti-tumor activity regardless of PD-L1 status and holds breakthrough potential in IO-resistant
More news about: INOVIO Pharmaceuticals, Inc.
Mar 04, 2026, 02:00 ET Fapon Biopharma to Present Next-Generation CD3/TCR VHH TCE Platform at 19th Annual European Life Sciences CEO Forum
translational timelines. The platform has already successfully completed evaluation demonstrating superior efficacy and safety as well as predictable PK/PD in mouse and NHP studies.With superior CMC profiles and flexibility for multi-valent formatting, Fapon Biopharma is seeking strategic partners
More news about: Fapon Biopharma
Mar 03, 2026, 10:05 ET Creatv Bio's LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn's Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer
CCR5 and PD-L1 from the tumor microenvironment.In prior studies, leronlimab induced PD-L1 expression on CTCs and CAMLS in 88% of metastatic breast cancer patients treated at doses above 525 mg/week, reinforcing the proposed ability of CCR5 blockade to convert "cold" tumors into "hot," PD-L1–positive
More news about: Creatv MicroTech, Inc.
Mar 03, 2026, 09:00 ET Linus Health to Present New Findings on Digital Risk Scores for Dementia and Patient-Centered Endpoints at Leading Global Alzheimer's and Parkinson's Conference
and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026), taking place March 17-21, 2026, in Copenhagen, Denmark, and online. AD/PD convenes thousands of scientists, clinicians, and industry leaders to share the latest advances in basic science, translational research, clinical insights,
More news about: Linus Health
Mar 03, 2026, 09:00 ET Power Metallic Intercepts Lion Style Sulphides (Lion East and Lion West) Following Recently Recognized High Grade Structural Trends
mineralization over 0.31m consisting of massive nickeliferous sulphides (2.42% Ni, 1.83 g/t Pd, 0.11% Cu) within a tonalite dyke. This mineralization is like the 'rafted' rip-up blocks seen at the Tiger deposit and indicate that a Ni-Pd-Cu deposit exists somewhere below the rafted block. Power Metallic has subsequently
More news about: Power Metallic Mines Inc.
Mar 03, 2026, 08:21 ET Cervoz представит решения для Edge AI на выставке Embedded World 2026: расширение возможностей периферийного искусственного интеллекта
предназначенная для обеспечения точности и долговечности в промышленной связи. Она дополняет новую плату расширения USB Type-C с поддержкой функций Power Delivery (PD) и DisplayPort (DP), а также новейшие модули Wi-Fi 7, обеспечивающие
More news about: Cervoz Technology Co., Ltd.
Mar 03, 2026, 08:10 ET CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI
leading the U.S. Medical Affairs Diagnostics team at Daiichi Sankyo, Inc. He is recognized for supporting FDA-approved companion diagnostics, including PD-L1, and for advancing digital pathology and AI-enabled biomarker assessment to improve clinical adoption and scalability."Ehab's track record leading
More news about: CellCarta
Mar 03, 2026, 08:01 ET BenQ Launches New 5K Glossy Monitor Purpose-Built for Mac Users
pre-order period, customers will receive 20% off the purchase of a second unit. This promotion also applies to BenQ's 5K monitor for designers, the PD2730S.For more information on the MA270S, visit
More news about: BenQ
Mar 03, 2026, 05:23 ET Cervoz bude vystavovať na Embedded World 2026: posilnenie riešení Edge s umelou inteligenciou
Award, ktorá je navrhnutá pre presnosť a odolnosť v priemyselnej komunikácii. Toto spája novú rozširujúcu kartu USB Type-C s funkciami Power Delivery (PD) a DisplayPort (DP) a najnovšie moduly Wi-Fi 7, čím poskytuje
More news about: Cervoz Technology Co., Ltd.
Mar 03, 2026, 05:22 ET Présence de Cervoz à Embedded World 2026 : solutions d'IA de périphérie
constitue le point d'orgue de la gamme de connectivité. Elle s'ajoute à la nouvelle carte d'extension USB Type-C avec les fonctionnalités Power Delivery (PD) et DisplayPort (DP), ainsi qu'aux derniers modules Wi-Fi 7, offrant
More news about: Cervoz Technology Co., Ltd.
Mar 03, 2026, 04:30 ET Cervoz to Exhibit at Embedded World 2026: Empowering Edge AI Solutions
expansion card, designed for precision and durability in industrial communication. This joins the new USB Type-C expansion card with Power Delivery (PD) and DisplayPort (DP) functionality, and the latest Wi-Fi 7 modules, providing
More news about: Cervoz Technology Co., Ltd.